Immunolocalization and characterization of the rat analogue of human CD59 in kidney and glomerular cells
- PMID: 7507093
- PMCID: PMC1422212
Immunolocalization and characterization of the rat analogue of human CD59 in kidney and glomerular cells
Abstract
CD59, a potent inhibitor of the human membrane attack complex (MAC) of complement, is present on many different tissues throughout the body. Recently we identified and characterized the rat analogue of CD59 and produced a number of monoclonal antibodies (mAb). We have now used these antibodies to demonstrate, by immunofluorescence microscopy, that rat CD59 was widely expressed in the rat kidney. Staining of renal sections revealed the presence of rat CD59 in abundance in the glomerulus, collecting ducts and distal tubules. Staining was abolished by treatment of sections with phosphatidylinositol-specific phospholipase C (PIPLC). Rat mesangial cells also stained strongly for rat CD59, giving an intensely granular staining pattern. In complement attack experiments the cultured mesangial cells were rendered more susceptible to lysis by rat or human complement after preincubation with the anti-inhibitor mAb. The results demonstrate that the rat analogue of CD59 is present and functionally active in rat renal tissue. The protective effect of CD59 against MAC-mediated tissue injury can now be examined in rat models of human renal disease.
Similar articles
-
The complement-inhibiting protein, protectin (CD59 antigen), is present and functionally active on glomerular epithelial cells.Clin Exp Immunol. 1991 Feb;83(2):251-6. doi: 10.1111/j.1365-2249.1991.tb05623.x. Clin Exp Immunol. 1991. PMID: 1704296 Free PMC article.
-
Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.Lab Invest. 1996 Jan;74(1):33-42. Lab Invest. 1996. PMID: 8569195
-
Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.Transplantation. 1994 Dec 15;58(11):1222-9. Transplantation. 1994. PMID: 7527603
-
The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.Immunology. 1993 Mar;78(3):349-57. Immunology. 1993. PMID: 7682985 Free PMC article.
-
Restriction factors of homologous complement: a new candidate?Immunol Today. 1990 Feb;11(2):47-9. doi: 10.1016/0167-5699(90)90017-4. Immunol Today. 1990. PMID: 1692222 Review. No abstract available.
Cited by
-
Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.Infect Immun. 2013 Aug;81(8):2678-85. doi: 10.1128/IAI.01079-12. Epub 2013 May 20. Infect Immun. 2013. PMID: 23690395 Free PMC article.
-
Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison.Immunology. 2003 May;109(1):117-26. doi: 10.1046/j.1365-2567.2003.01628.x. Immunology. 2003. PMID: 12709025 Free PMC article.
-
Urine complement analysis implies complement activation is involved in membranous nephropathy.Front Med (Lausanne). 2025 Feb 13;12:1515928. doi: 10.3389/fmed.2025.1515928. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40018357 Free PMC article.
-
Molecular cloning of the rat analogue of human CD59: structural comparison with human CD59 and identification of a putative active site.Biochem J. 1994 Dec 1;304 ( Pt 2)(Pt 2):595-601. doi: 10.1042/bj3040595. Biochem J. 1994. PMID: 7528012 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous